BAYO OWENS: Open Payments
NPI 1134884356 · MIDDLETOWN, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,157 in 27 payments from 9 companies in 2025. Trend: 2023 $2,915 · 2024 $757 · 2025 $1,157
Food & beverage: $1,046Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 4 | $231 |
| ABBVIE INC. | 9 | $216 |
| Alkermes, Inc. | 4 | $204 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $196 |
| Janssen Pharmaceuticals, Inc | 2 | $125 |
| Neurocrine BioSciences, Inc. | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: VRAYLAR, CAPLYTA, ARISTADA, AUSTEDO XR, INVEGA SUSTENNA, INGREZZA, LYBALVI, TRINTELLIX.
Industry payments across RI — which companies pay providers there.
